REGENERON PHARMACEUTICALS, INC. (REGN) Income statement
Top 20 of 27 line items reported by REGN · 250+ in the full API →
REGENERON PHARMACEUTICALS, INC. (REGN) · Income Statement
Consolidated Statements of Operations
Quarterly · In millions USD, except per-share data · Latest filed Oct 30, 2026 · FY ends Dec 31
| Three Months Ended | ||||||
|---|---|---|---|---|---|---|
Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Trend | |
| Total Revenue | $5,116 | $4,291 | $3,605 | $3,884 | $3,754 | |
| Cost of Revenue | 574 | 577 | 669 | 585 | 522 | |
| Gross Profit | $4,542 | $3,714 | $2,936 | $3,300 | $3,233 | |
| Other Operating Expenses | 2,494 | 2,421 | 2,293 | 2,420 | 2,206 | |
| Total Operating Expenses | 3,068 | 2,997 | 2,963 | 3,004 | 2,728 | |
| Operating Income | $2,048 | $1,294 | $643 | $880 | $1,027 | |
| EBIT (Earnings Before Interest & Tax) | 2,048 | 1,294 | 643 | 880 | 1,027 | |
| Add: Depreciation & Amortization | 121 | 124 | 123 | 145 | 137 | |
| EBITDA (Non-GAAP) | $2,169 | $1,417 | $766 | $1,025 | $1,164 | |
| Interest Expense | -11 | -11 | -13 | -12 | -19 | |
| Investment Gains (Losses) | 58 | — | — | (11) | 577 | |
| Non-Operating Income (Expense) | $236 | $234 | $188 | $164 | $737 | |
| Income Before Taxes (EBT) | $2,284 | $1,528 | $831 | $1,044 | $1,763 | |
| Provision for Income Taxes | 335 | 231 | 104 | 199 | 303 | |
| Effective Tax Rate | 14.7% | 15.1% | 12.5% | 19.1% | 17.2% | |
| Net Income | $1,949 | $1,297 | $727 | $845 | $1,460 | |
| Shares Outstanding | 102 | 103 | 104 | 103 | 104 | |
| Diluted Shares Outstanding | 106 | 106 | 108 | 108 | 107 | |
| Diluted Earnings Per Share | $18.45 | $12.23 | $6.75 | $7.84 | $13.62 | |
| Gross Margin | 88.8% | 86.6% | 81.4% | 84.9% | 86.1% | |
7 more line items available via the API
Research & DevelopmentSales, General & AdministrativeGain (Loss) on Equity SecuritiesBasic Earnings Per ShareOperating MarginOther OpEx MarginNet Margin
Ask your agent:
get_financialsAPIGET /api/v1/companies/REGN/income-statement?period=quarterly&years=2Docs →